HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Megumi Nakanishi Selected Research

Megumi Nakanishi Research Topics

Disease

2Multiple Sclerosis
05/2006 - 04/2005
1Rheumatoid Arthritis
11/2022
1Fetal Distress
05/2022
1Neuroinflammatory Diseases
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2018
1Neoplasms (Cancer)
12/2018
1Peritonitis
10/2018
1Surgical Wound Infection
10/2018
1Inflammation (Inflammations)
05/2018
1Progressive Multifocal Leukoencephalopathy
08/2013
1Ischemic Stroke
01/2013
1Stroke (Strokes)
01/2013
1Mcleod Type Neuroacanthocytosis
04/2007
1Inborn Genetic Diseases (Disease, Hereditary)
04/2007
1Neuroacanthocytosis
04/2007
1Huntington Disease (Huntington's Disease)
04/2007
1Dyskinesias (Dyskinesia)
04/2007
1Paraneoplastic Cerebellar Degeneration
05/2005
1Lymphoma (Lymphomas)
04/2005

Drug/Important Bio-Agent (IBA)

2Complementary DNA (cDNA)IBA
05/2006 - 04/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022
1Methotrexate (Mexate)FDA LinkGeneric
11/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1GemcitabineFDA Link
12/2018
1Carcinoembryonic AntigenIBA
12/2018
1Messenger RNA (mRNA)IBA
12/2018
1Immunoglobulin G (IgG)IBA
05/2018
1Interleukin-6 (Interleukin 6)IBA
05/2018
1CytokinesIBA
01/2013
1Creatine Kinase (Creatine Phosphokinase)IBA
04/2007
1AntibodiesIBA
04/2007
1AntigensIBA
05/2005
1Proteins (Proteins, Gene)FDA Link
04/2005
1TNF-Related Apoptosis-Inducing LigandIBA
04/2005
1Receptor-Interacting Protein Serine-Threonine Kinase 2 (CARDIAK)IBA
04/2005
1Member 2 Group A Nuclear Receptor Subfamily 4IBA
04/2005

Therapy/Procedure

3Therapeutics
11/2022 - 12/2018
1Cesarean Section (Caesarean Section)
05/2022
1Conservative Treatment
05/2022
1Negative-Pressure Wound Therapy
10/2018
1Kidney Transplantation
08/2013
1Thrombolytic Therapy
01/2013